Novel immunotherapy for peritoneal dissemination of murine colon cancer with macrophage inflammatory protein-1β mediated by a tumor-specific vector, HVJ cationic liposomes
- 1 November 2001
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 8 (11), 852-860
- https://doi.org/10.1038/sj.cgt.7700384
Abstract
Cancer Gene Therapy is the essential gene therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene therapy for cancer.Keywords
This publication has 43 references indexed in Scilit:
- Transforming growth factor-β1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstructionKidney International, 2000
- Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomesGene Therapy, 2000
- CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines.Journal of Clinical Investigation, 1998
- Sustained transgene expression in vitro and in vivo using an Epstein–Barr virus replicon vector system combined with HVJ liposomesGene Therapy, 1998
- Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposomeGene Therapy, 1998
- Development and Characterization of Cationic Liposomes Conjugated with HVJ (Sendai Virus): Reciprocal Effect of Cationic Lipid forIn VitroandIn VivoGene TransferHuman Gene Therapy, 1997
- Functional diversity of helper T lymphocytesNature, 1996
- Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene ImmunizationScience, 1996
- Actions of the chemotactic cytokines MCP‐1, MCP‐2, MCP‐3, RANTES, MIP‐1α and MIP‐1β on human monocytesEuropean Journal of Immunology, 1995
- The improved efficient method for introducing macromolecules into cells using HVJ (Sendai virus) liposomes with gangliosidesExperimental Cell Research, 1987